Postdoctoral Fellowship in the Vliagoftis/Kane Lab

MED Medicine Department

Competition No.  -    A104447995
Closing Date  -    Will remain open until filled.

This position is a part of the Association of the Academic Staff of the University of Alberta (AASUA).

This position offers a benefits package found at Postdoctoral Fellows Benefits.


Work primarily takes place at North Campus Edmonton.

Working for the University of Alberta

The University of Alberta acknowledges that we are located on Treaty 6 territory, and respects the histories, languages and cultures of First Nations, Métis, Inuit and all First Peoples of Canada, whose presence continues to enrich our vibrant community.

The University of Alberta is teeming with change makers, community builders, and world shapers who lead with purpose each and every day. We are home to more than 40,000 students in 200+ undergraduate and 500+ graduate programs, over 13,000 faculty and staff, 260,000 alumni worldwide and have been recognized as one of Canada’s Greenest Employers for over a decade.

Your work will have a meaningful influence on a fascinating cross section of people—from our students and stakeholders, to our renowned researchers and innovators who are quite literally curing diseases, making discoveries and generating solutions that make the world healthier, safer, stronger, and more just.

Working for the Department/Faculty Summary

Our combined lab (Vliagoftis and Kane labs) has been working on the development of a novel adjuvant for mucosal vaccination. The main ideas of the project are the continuation of the work presented in a recent publication by our group: G Zhou et al, J Immunol, 2019; 203: 441-452. The labs are affiliated with the Departments of Medicine and Medical Microbiology and Immunology and the appointment will be with one of the two Departments. 

Position Summary

One position for a post-doctoral fellow is open at the Kane/Vliagoftis lab.

The successful candidate will work on a research project funded by CIHR. The main aim of the project is to understand the mechanism of action of a new mucosal vaccination adjuvant and define its clinical utility using preclinical animal models.

Funding for up to 2 years is available, but the successful candidate will also be encouraged to look for external funding for their studies.


  • Perform experiments to understand the mechanisms of action of the novel adjuvant
  • Analyze immune changes in mice after vaccination through flow cytometry, in vitro assays of immune cell activation, ELISA and other immune techniques
  • Develop in vitro models to test the immunostimulatory effects of the adjuvant on innate and adaptive immune cells

Minimum Qualifications

  • PhD in Immunology or related disciplines obtained within the last 5 years
  • Able to work with small animals
  • Experience with immune assays including: characterization of T cell subsets by flow cytometry, in vitro immune cell activation and other techniques,
  • Working knowledge of data visualization, interpretation, presentation, and reporting software (i.e. Excel, PowerPoint and others)

Preferred Qualifications

  • Experience with studies on vaccine efficacy
  • Experience with mouse studies

How to Apply

Apply Online

Note: Online applications are accepted until midnight Mountain Standard Time of the closing date.

All qualified candidates are encouraged to apply; however, Canadians and permanent residents will be given priority. If suitable Canadian citizens or permanent residents cannot be found, other individuals will be considered. The University of Alberta is committed to an equitable, diverse, and inclusive workforce. We welcome applications from all qualified persons. We encourage women; First Nations, Métis and Inuit persons; members of visible minority groups; persons with disabilities; persons of any sexual orientation or gender identity and expression; and all those who may contribute to the further diversification of ideas and the University to apply.